Keloid Scars
Conditions
Keywords
Keloid, Vancouver scar scale, Triamcinolone, Verapamil, Intralesional injection
Brief summary
This study aims to compare the efficacy of intralesional triamcinolone and verapamil in patients presenting with keloid at our local setting. The results will guide us towards better management of keloids by choosing the more appropriate treatment. Adequate treatment will reduce significant emotional and physical distress in patients. We hypothesized that mean reduction in Vancouver Scar Score is higher in triamcinolone acetonide group compared to verapamil after three months of treatment.
Interventions
Monthly intralesional injection
2.5 mg of intralesional Verapamil injection monthly
Sponsors
Nishtar Medical University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
10 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* size of keloid1-5 cm, * on any site of the body, * duration less then five years and * baseline Vancouver scar score of more the or equal to 5
Exclusion criteria
* Pregnant or lactating women, * family history of keloids, * acromegaly, and * congestive cardiac diseases
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Vancouver Scar Score | Vancouver Scar score will be measured at baseline (before treatment assignment) and then 4-weeks after completion of treatment - 16-weeks after randomization. | The Vancouver Scar scale assesses four parameters of vascularity, pigmentation, pliability and height. The total score ranges from 0 - 13. |
Countries
Pakistan
Contacts
Primary ContactDr. Asma Batool, MBBS
Outcome results
None listed